Adv. Daniel Green represented Reshef Technologies, an Israeli company, in negotiations with Baharat Electronics, one of India's largest defense companies, for a strategic technology transfer and supply agreement worth tens of millions of dollars.  The transaction also included assistance in establishing a plant in India for assembling electronic fuses for land-based ammunition.
 

Advocates Barak S. Platt, Ben Sandler, Ofir Levy, Daniel Green, Eli Greenbaum and Nimrod Vromen represented Clarity Ray, an Israeli startup company developing tools helping publishers and networks identify and prevent ad-fraud, in its acquisition by Yahoo!.
Adv. Kobi Ben Chitrit and Liron Hacohen represented the Company's lead investor, Mr. Saar Wilf.
Clarity Ray's employees will be used by Yahoo! to form its new local R&D hub focusing on internet search frauds. 
 

Advocates Barry Levenfeld, Harry Kirsh, Yuval Shalhevet, Zohar Nevo and Noam Enk represents the winning bidding consortium, consisting of Johnson & Johnson, Takeda Pharmaceuticals (the first Japanese Pharmaceutical Company to invest in Israel) and the healthcare fund OrbiMed Israel, for the establishment of an OCS-supported biotechnological incubator intended to encourage the creation and support of pharmaceutical and medical device companies.

Advs. Barry Levenfeld, Eric Spindel, Avigail Frisch and Noam Enk represented Aegis for Alcobra Ltd.'s initial public offering on Nasdaq. Alcobra Ltd., headquartered in Israel, is an emerging biopharmaceutical company primarily focused on the development and commercialization of a proprietary drug to treat Attention Deficit Hyperactivity Disorder.